Description
Colitis disease activity and intestinal barrier function data from mice treated with crocetin (saffron-derived compound) during DSS-induced colitis recovery, assessing body weight, colon length, and histological damage.
Figure 4
ChartSource Paper
Crocetin Prolongs Recovery Period of DSS-Induced Colitis via Altering Intestinal Microbiome and Increasing Intestinal Permeability.Cite This Figure
![Figure 4: Colitis disease activity and intestinal barrier function data from mice treated with crocetin (saffron-derived compound) during DSS-induced colitis recovery, assessing body weight, colon length, and histological damage.]() > Source: Peishi Feng et al. "Crocetin Prolongs Recovery Period of DSS-Induced Colitis via Altering Intestinal." *International journal of molecular sciences*, 2022. PMID: [35409192](https://pubmed.ncbi.nlm.nih.gov/35409192/)
<figure> <img src="" alt="Colitis disease activity and intestinal barrier function data from mice treated with crocetin (saffron-derived compound) during DSS-induced colitis recovery, assessing body weight, colon length, and histological damage." /> <figcaption>Figure 4. Colitis disease activity and intestinal barrier function data from mice treated with crocetin (saffron-derived compound) during DSS-induced colitis recovery, assessing body weight, colon length, and histological damage.<br> Source: Peishi Feng et al. "Crocetin Prolongs Recovery Period of DSS-Induced Colitis via Altering Intestinal." <em>International journal of molecular sciences</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35409192/">35409192</a></figcaption> </figure>